Latest Breaking News On - Drug development company to deepen ip moat - Page 1 : vimarsana.com

And continued successful execution of R&D and Commercialization strategies Toronto, Ontario (Newsfile Corp. - December 15, 2022) - Awakn Life Sciences Corp.(NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn")

United kingdomNew yorkUnited statesCity ofGordo whittakerCatalent zydisAnthony tennysonLinkedin facebookAwakn life sciencesDrug development company to deepen ip moatInternational financial reporting standardsAwakn life sciences signs drug development agreementAwakn life sciences corpAwakn life sciences signs agreementNewsfile corpAwakn life sciences announces signing of lease